Neuro-Ophthalmic Complications of Immune Checkpoint Inhibitors

Key Points

• Ocular inflammation is a significant complication of immune checkpoint inhibitors, impacting patient care.
• In a review of reported cases, 30% of patients with these treatments experienced neuro-ophthalmic complications.
• Assessment using patient records highlighted the necessity for vigilant monitoring of ocular symptoms during treatment.
• Further research is necessary to understand long-term ocular effects and establish preventive measures.